Verve for VERxVE

An extended release formulation breaks through by Chael Needle Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...

The Early Days

LifeGuide Dr. C. Everett Koop Revisits a Time When Neither Treatment nor Testing Existed by Chael Needle Knowing he had to face the micromanaging tendencies and...

Bio Logic

A bacterium with a live biotherapeutic grows into a microbicide candidate by Chael Needle LifeGuide The development of female-initiated HIV prevention methods—female condoms, antiretroviral treatment as prevention,...

Protecting the Pipeline

LifeGuide HIV drug development faces challenges by Jeannie Wraight and Mariel Selbovitz, MPH Triple and now quad drugs like Gilead’s Atripla and their new compound known...

Mighty Mouse

Mighty Mouse A humanized BLT mouse model creates a vital platform for drug discovery by Chael Needle In the early stages of drug discovery, many candidates that...

AMBER Study: Phase 3 Symtuza Results

At the 16th European AIDS Conference in Milan, Italy, on October 25, 2017, Janssen Pharmaceutica, NV announced the results of its Phase 3 AMBER...

Speed Test

An antigen and antibody combo assay zeroes in on acute infection Treatment Horizons by Chael Needle The diagnosis of acute HIV infection, when the virus is...

The Road Ahead

LifeGuide Treatment Horizons The Road Ahead New candidates hold promise for ARV therapy & therapeutic vaccines by Mariel Selbovitz, MPH The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...

Women’s HIV Program: Empowerment Is Treatment

Undetectable is a worthy goal, no doubt about it. A suppressed viral load very often means the individual living with HIV is adherent to...

Undetectable = Untransmittable Reconfirmed by New Study, Embraced at IAS 2017

A newly completed study of 358 serodiscordant gay couples has not found a single case of HIV transmission in 16,889 acts of condomless anal...

LATEST POSTS

$210M Funding Opportunity for CBOs

CDC Announces $210M Funding Opportunity for CBOs On September 28, 2020, the Centers for Disease Control and Prevention (CDC) announced the availability in fiscal 2021...

High Flight